Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2008
10/09/2008US20080248998 Glyceryl stearate or glyceryl palmitostearate to mask bad flavor of drugs; anti-bacterial, antifungal, metronidazole, anti-parasitic, nivaquine, antiviral, anti-cancer, analgesics, non-steroidal anti-inflammatories, anti-tussives, psychotropic, steroids, anti-histamines, anti-allergic agents
10/09/2008US20080248566 Matriptase, a serine protease and its applications
10/09/2008US20080248140 of Valerian root and an effective amount Methylcobalamin; induction of sedation and providing anxiolytic compounds and melatonin support
10/09/2008US20080248098 Polysaccharide Microparticles Containing Biological Agents: Their Preparation and Applications
10/09/2008US20080248088 Decontaminant edible product, methods of production and uses thereof
10/09/2008US20080248066 Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods using the modified microbes for the activation antigens
10/09/2008US20080248052 Vitamin receptor binding drug delivery conjugate
10/09/2008US20080248048 Interleukin receptor specific immunoglobulin for use in diagnosis, prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary, scleroderma, inflammatory bowel and Hodgkin's diseases
10/09/2008US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders
10/09/2008US20080248039 Antibodies Against Histone Modifications for Clinical Diagnosis and Prognosis of Cancer
10/09/2008US20080248038 Combination of an anti ED-B fibronectin domain antibody and an anti-EGFR-antibody
10/09/2008US20080248037 Death receptor-5 (DR-5) specific immunoglobulin for use in treatment and prevention of cell proliferative and immune related disorders
10/09/2008US20080248036 Treatment with anti-vegf antibodies
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248028 Immunoadhesin comprising modified Fc gamma R segment for use as targeting diagnostic and/or therapeutic in treatment of cell proliferative disorders
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248020 Variant lyase for use in treatment and prevention of cell proliferative disorders
10/09/2008US20080248016 Novel Iaccase Enzymes and Their Uses
10/09/2008US20080248011 Immunoglobulin for identifying cells expressing monocyte integral membrane proein (HIDE-1); inducing propagation of dendritic cell for use in treatment of autoimmune, tumor and organ rejection disorders
10/09/2008US20080248003 Methods and Compositions for Growing Adipose Stem Cells
10/09/2008US20080248000 CD14 and CD34 expressing adult stem cell culture for use in treatment of vascular disorders; tissue engineering and repair; regenerative medicine
10/09/2008US20080247997 External animal layer sanitation using bacteriophage
10/09/2008US20080247957 Administering injectable, echogenic nanocapsule and/or microcapsule comprising drug, targeting moiety, or both; biodegradation
10/09/2008US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening
10/09/2008US20080247945 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome
10/09/2008US20080247944 Human monoclonal antibodies; encoded by nucleic acids; anticancer agents
10/09/2008CA2682736A1 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682567A1 Non-peptidic molecules for detecting and treating tumors
10/09/2008CA2682531A1 A system and method of acquiring instant credit
10/09/2008CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2682129A1 Crystal forms and uses thereof
10/09/2008CA2682125A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2680407A1 Prophylactic and/or therapeutic agent for hyperlipidemia
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978033A2 Human antibodies derived from immunized xenomice
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977753A1 Combined preparation comprising anthracycline derivatives
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976544A2 Method of using guava extract and composition including guava extract
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1523469B1 Cinnamide derivatives
10/08/2008EP1499360B1 Formulation comprising buprenorphine
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1485363B1 Cyclic amides
10/08/2008EP1476128B1 Lipase inhibiting composition
10/08/2008EP1465521A4 System and method for the pretreatment of the endplates of an intervertebral disc
10/08/2008EP1455600B1 Food or pet food composition containing plant extract from amelanchier for bone health
10/08/2008EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1370298B1 Elongated and multiple spacers in activatible prodrugs
10/08/2008EP1357811B1 Composition and method for smoke detoxification
10/08/2008EP1344528B1 External skin preparations and process for producing the same
10/08/2008EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/08/2008EP1189626B1 Composition for preventing tumoral growth
10/08/2008EP1137762B1 Treatment of pompe's disease
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1044015B1 Formulations for amylin agonist peptides with insulin
10/08/2008EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/08/2008EP0804580B1 Calcium binding recombinant antibody against protein c
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101279983A 抗肿瘤联合药物 Joint anti-tumor drugs
10/08/2008CN101279971A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same
10/08/2008CN101279955A N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
10/08/2008CN101278935A Medical composition containing derivative of vitamin B group
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100424161C Wine and its brewing method
10/08/2008CN100424093C Peptides which can bind to transforming growth factor beta 1 (tgf-beta1)
10/08/2008CN100423774C Process for preparing polysaccharide-protein conjugate vaccines
10/08/2008CN100423773C Application of edestin in preparation of medicament
10/08/2008CN100423721C Thrombopoietin mimetics
10/08/2008CN100423718C Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
10/08/2008CN100423717C Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
10/07/2008US7433788 Crystallization of IGF-1
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
10/07/2008US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432354 Polypeptide or fragment recognized by tumor-specific cytotoxic T lymphocytes; anticancer vaccines
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432304 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008US7432250 Oligoribonucleotides and ribonucleases for cleaving RNA
10/07/2008US7432249 Oligoribonucleotides and ribonucleases for cleaving RNA
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent
10/07/2008US7431953 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts
10/07/2008US7431943 Controlled release and taste masking oral pharmaceutical compositions
10/07/2008US7431932 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition; reducing the risk of introducing or reintroducing neoplastic cells into the recipient
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 1564